Atara Biotherapeutics Statistics
Total Valuation
ATRA has a market cap or net worth of $51.92 million. The enterprise value is $80.02 million.
Important Dates
The next estimated earnings date is Monday, August 11, 2025, after market close.
| Earnings Date | Aug 11, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
ATRA has 5.96 million shares outstanding. The number of shares has increased by 90.64% in one year.
| Current Share Class | 5.96M |
| Shares Outstanding | 5.96M |
| Shares Change (YoY) | +90.64% |
| Shares Change (QoQ) | +1.32% |
| Owned by Insiders (%) | 2.42% |
| Owned by Institutions (%) | 38.27% |
| Float | 3.47M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 5.27 |
| PS Ratio | 0.38 |
| Forward PS | 1.78 |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 0.40 |
| EV / EBITDA | 35.81 |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.57
| Current Ratio | 0.57 |
| Quick Ratio | 0.47 |
| Debt / Equity | n/a |
| Debt / EBITDA | 2.23 |
| Debt / FCF | n/a |
| Interest Coverage | -0.72 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -1.77% |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | -22.76% |
| Revenue Per Employee | $1.31M |
| Profits Per Employee | -$102,229 |
| Employee Count | 153 |
| Asset Turnover | 1.76 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -36,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -38.02% in the last 52 weeks. The beta is 0.18, so ATRA's price volatility has been lower than the market average.
| Beta (5Y) | 0.18 |
| 52-Week Price Change | -38.02% |
| 50-Day Moving Average | 7.16 |
| 200-Day Moving Average | 8.82 |
| Relative Strength Index (RSI) | 61.66 |
| Average Volume (20 Days) | 76,665 |
Short Selling Information
The latest short interest is 367,405, so 6.16% of the outstanding shares have been sold short.
| Short Interest | 367,405 |
| Short Previous Month | 412,857 |
| Short % of Shares Out | 6.16% |
| Short % of Float | 10.58% |
| Short Ratio (days to cover) | 5.00 |
Income Statement
In the last 12 months, ATRA had revenue of $199.73 million and -$15.64 million in losses. Loss per share was -$1.78.
| Revenue | 199.73M |
| Gross Profit | 35.56M |
| Operating Income | -3.22M |
| Pretax Income | -233.09M |
| Net Income | -15.64M |
| EBITDA | 2.24M |
| EBIT | -3.22M |
| Loss Per Share | -$1.78 |
Full Income StatementBalance Sheet
The company has $13.84 million in cash and $41.94 million in debt, giving a net cash position of -$28.10 million or -$4.71 per share.
| Cash & Cash Equivalents | 13.84M |
| Total Debt | 41.94M |
| Net Cash | -28.10M |
| Net Cash Per Share | -$4.71 |
| Equity (Book Value) | -55.07M |
| Book Value Per Share | -9.30 |
| Working Capital | -20.71M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$67.24 million and capital expenditures -$119,000, giving a free cash flow of -$67.36 million.
| Operating Cash Flow | -67.24M |
| Capital Expenditures | -119,000 |
| Free Cash Flow | -67.36M |
| FCF Per Share | -$11.30 |
Full Cash Flow StatementMargins
Gross margin is 17.81%, with operating and profit margins of -1.61% and -7.83%.
| Gross Margin | 17.81% |
| Operating Margin | -1.61% |
| Pretax Margin | -7.85% |
| Profit Margin | -7.83% |
| EBITDA Margin | 1.12% |
| EBIT Margin | -1.61% |
| FCF Margin | n/a |
Dividends & Yields
ATRA does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -90.64% |
| Shareholder Yield | -90.64% |
| Earnings Yield | -30.12% |
| FCF Yield | -129.73% |
Analyst Forecast
The average price target for ATRA is $17.75, which is 103.79% higher than the current price. The consensus rating is "Buy".
| Price Target | $17.75 |
| Price Target Difference | 103.79% |
| Analyst Consensus | Buy |
| Analyst Count | 5 |
| Revenue Growth Forecast (5Y) | 7.82% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on June 20, 2024. It was a reverse split with a ratio of 0.04:1.
| Last Split Date | Jun 20, 2024 |
| Split Type | Reverse |
| Split Ratio | 0.04:1 |
Scores
ATRA has an Altman Z-Score of -42.57 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -42.57 |
| Piotroski F-Score | 2 |